asTas (DSJP — DrugShortage.jp medical drug supply status database) — Day-by-day national inventory of Japanese prescription-drug supply status, hand-compiled from the official notice pages of roughly 170 pharmaceutical manufacturers plus Ministry of Health, Labour and Welfare feeds: per drug code and per packaging-specification status (normal / limited shipment / supply suspension and adjacent tiers), drug and insurance price codes, generic / AG / selected-therapy classifications, manufacturer and trade-name tags, substitute-equivalence mapping, and a preserved daily change log.. A national-s…
asTas (DSJP — DrugShortage.jp medical drug supply status database) — Day-by-day national inventory of Japanese prescription-drug supply status, hand-compiled from the official notice pages of roughly 170 pharmaceutical manufacturers plus Ministry of Health, Labour and Welfare feeds: per drug code and per packaging-specification status (normal / limited shipment / supply suspension and adjacent tiers), drug and insurance price codes, generic / AG / selected-therapy classifications, manufacturer and trade-name tags, substitute-equivalence mapping, and a preserved daily change log.. A national-s…
Drugshortage offers (Alternative, Supply Chain, Reference) — As of a 2026 snapshot the live index covers roughly 2,900 items under shipment adjustment, equivalent to about 7,600 packaging-specification records, plus full supply status for the wider prescription catalogue. Daily change volume is small but continuous — the home page logs dated change counts (for example 11 changes in the ministry feed on one recent day) against an intake of roughly 170 monitored manufacturer sites..
Drug-shortage nowcasting and forecasting; procurement and substitution decision models for hospitals, pharmacies and wholesalers; supply-chain exposure scoring for manufacturers and generic producers; causal event studies of shortage impact on dispensing; and training data for models that map unstructured company notice pages into structured status codes, since the association's own workflow is exactly that mapping by hand.
The data is with 5 years of history.
Coverage spans Japan, US; Pharmaceuticals, Drug Retail; alternative, supply_chain, reference; equities.
Not yet on file: Summary & mission · Use cases & buyers · FAQ